Tania Patel, OD
Optometrist · Lexington, KYNPI 1962855437
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,314 of the $5,516 with a category attached, or 78.2%. 18 manufacturers reported payments, led by Alcon at 33.1% of the total. Reporting peaked in 2019 at $3,117 and has fallen 78.4% since, to $675 in 2025. Among optometrist clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $51.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Johnson & Johnson Vision Care, Inc.$1K
- AbbVie$698
- Lensar, Inc.$276
- Sun Pharmaceutical Industries Inc.$187
- Shire North American Group Inc$144
- plus $896 from 12 others
What the payments were for
- Speaking & faculty fees$260%
- Travel & lodging$1,09720%
- Food & beverage$4,31478%
- Education$801%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 21 | $1,824 |
| Johnson & Johnson Vision Care, Inc. | 15 | $1,490 |
| AbbVie(2 entities) | 29 | $698 |
| Lensar, Inc. | 6 | $276 |
| Sun Pharmaceutical Industries Inc. | 10 | $187 |
| Shire North American Group Inc | 2 | $144 |
| Kala Pharmaceuticals, Inc. | 2 | $133 |
| Aerie Pharmaceuticals, Inc. | 2 | $132 |
| Novartis | 1 | $118 |
| Ocular Therapeutix, Inc. | 1 | $118 |
| Rxsight Inc | 3 | $78 |
| Bausch & Lomb Americas Inc. | 4 | $67 |
| Tarsus Pharmaceuticals, Inc. | 3 | $66 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $66 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $43 |
| LKC Technologies, Inc. | 2 | $32 |
| Rayner Intraocular Lenses Limited | 1 | $24 |
| Oyster Point Pharma, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$1,235
- Acuvue$1,150
- AIR OPTIX$532
- DEXTENZA$354
- XIIDRA$240
- AcrySof IQ PanOptix$233
- LENSAR LASER SYSTEM$229
- RESTASIS$125
- EYSUVIS$121
- ReSure Sealant$118
- Rhopressa$111
- Rocklatan$111
- LUMIGAN$109
How this compares
$5,516 in reported general payments places this provider in the 90th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 109 | $57,616 |
| ErythromycinErythromycin Base | 782 | $7,653 |
| CombiganBrimonidine Tartrate/Timolol | 11 | $3,796 |
| Atropine Sulfate | 106 | $2,421 |
| Alphagan PBrimonidine Tartrate | 13 | $2,355 |
| Latanoprost | 168 | $1,522 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 33 | $503 |
| Timolol Maleate | 24 | $284 |
| Tobramycin | 26 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $698 | $63,766133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 712 optometrist providers in Kentucky.
Other optometrist in Lexington
- Paul KarpeckiLexington$3.6M
- Bilal AhmadLexington$150K
- Christopher KucLexington$52K
- Joe McMillinLexington$11K
- Karen McMillinLexington$10K
- Danielle FrankLexington$5K
- Ashley LaneLexington$5K
- Steven SpearLexington$5K
- Howell FindleyLexington$5K
- Lisa WangLexington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.